casalonga logo

Case Law

Here you will find a selection of decisions from French and European courts, authorities, and offices. Various teams at CASALONGA were involved in some of the cases handled. Other cases are mentioned here due to their particular importance

2023-09-06

French Supreme Court, Commercial Chamber - DAIICHI v/ BIOGARAN, INPI and others


Validity of the notification of the revocation decision to the representative appointed to file the supplementary protection certificate (hereinafter SPC) - Payment of annuities by another representative does not constitute appointment.

BIOGARAN was represented by the CASALONGA team, composed of Floriane Codevelle and Arnaud Casalonga, attorneys-at-law at the Paris Bar, and Gérard Dossmann, patent attorney, in a SPC infringement and unfair competition action brought by DAIICHI SANKYO and SANOFI.

BIOGARAN is a French pharmaceutical company specializing in generic drugs. DAIICHI is a Japanese company engaged in pharmaceutical research and development company, as well (...)
2023-03-23

European Patent Office, Enlarged Board of Appeal - SUMITOMO CHEMICALl Company, Limited v/ SYNGENTA Limited


A patent applicant or proprietor may rely upon a technical effect for inventive step if the skilled person, having the common general knowledge in mind, and based on the application as originally filed, would derive said effect as «(i) being encompassed by the technical teaching and (ii) embodied by the same originally disclosed invention».

By interlocutory decision T 116/18 of October 11, 2021, Technical Board of Appeal 3.3.02 referred questions to the Enlarged Board of Appeal (hereinafter the Enlarged Board) to (...)
2023-03-22

Paris Court of Appeal, Division 5, 2nd Chamber - NOVARTIS v/ BIOGARAN


Inadmissibility of summary proceedings based on a patent application not yet granted.

BIOGARAN was represented by the CASALONGA team, composed of Marianne Gabriel, and Arnaud Casalonga, attorneys-at-law at the Paris Bar, and Jean-Baptiste Lecoeur, attorney-at-law at the Paris Bar and patent attorney, in the first action in France related to "Fingolimod".

NOVARTIS AG held European patent application designating France No. 2 959 894 (hereinafter EP 894) entitled “S1P receptor modulators for treating multiple sclerosis” filed as a (...)
2023-02-16

Court of Justice of the European Union - MONZ HANDELSGESELLSCHAFT LNTERNATIONAL MBH & CO. KG v/ BÜCHEL GMBH & CO. FAHRZEUGTECHNIK KG.


The normal use of a complex product is interpreted both from the perspective of the end user and that of an external observer. This normal use includes the storage and transportation of the complex product but excludes its maintenance, service, or repair.

Monz, German company, owns a German national registered design from 2011 for “saddles for bicycles or motorcycles”: A second German company, Büchel, filed an application for (...)
2023-01-27

Paris Court of Appeal - SAS LES BIENHEUREUX v/ WATERLOGIC SVERIGE AB


Confirmation of similarity between non-alcoholic and alcoholic beverages.

Waterlogic Sverige AB was represented by the CASALONGA team, composed of Karina Dimidjian-Lecomte, Attorney at Law at the Paris and New York Bars, and Klervi Henry, Attorney at Law at the Paris and Montreal BarS.

On the basis of its European Union Trademark Registration THOREAU protected for “bottles, bottle cases, dish drainers and non-alcoholic beverages”, the Opponent filed an (...)